Clinical efficacy of Daikenchuto (DKT: TJ-100) for gastrointestinal symptoms in patients with history of colorectal cancer surgery; crossover study - Gastrointestinal transit time as an indicator -
Phase of Trial: Phase III
Latest Information Update: 05 Jun 2018
At a glance
- Drugs TJ 100 (Primary)
- Indications Gastrointestinal disorders
- Focus Pharmacodynamics
- 31 May 2018 Status changed from not yet recruiting to completed.
- 12 Mar 2013 Planned End Date changed from 1 Mar 2013 to 1 Mar 2015 as reported by University Hospital Medical Information Network - Japan.
- 11 Apr 2012 New trial record